Literature DB >> 30223962

Genetics of Hypercoagulable and Hypocoagulable States.

Daulath Singh1, Arjun Natarajan2, Sucha Nand3, Hanh P Mai3.   

Abstract

Hemostasis is the normal process of blood coagulation in vivo to stop pathologic bleeding. Virchow triad includes venous stasis, hypercoagulability, and vascular injury. Natural anticoagulants include protein C, protein S, and antithrombin. Factor V Leiden is the most common inherited thrombophilia, followed by prothrombin gene mutation. All inherited thrombophilias are passed down in an autosomal dominant fashion. Patients harboring the antiphospholipid antibodies have an increased risk for thrombosis. von Willebrand disease is the most common inherited bleeding disorder; the pattern of inheritance is autosomal. Hemophilia A and B are the only hereditary bleeding disorders inherited in a sex-linked recessive pattern.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiphospholipid syndrome; Antithrombin deficiency; Factor V Leiden; Hemophilia; Protein C and S deficiencies; Prothrombin gene mutation; von Willebrand disease

Mesh:

Year:  2018        PMID: 30223962     DOI: 10.1016/j.nec.2018.06.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

1.  Tranexamic acid is safe and effective in patients with heterozygous factor V Leiden mutation during total joint arthroplasty.

Authors:  Ali Levent; Ozkan Kose; Philip Linke; Thorsten Gehrke; Mustafa Citak
Journal:  Arch Orthop Trauma Surg       Date:  2021-08-03       Impact factor: 3.067

2.  Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population.

Authors:  Eray Yıldız; Funda Müşerref Türkmen
Journal:  J Transl Int Med       Date:  2020-12-31

3.  Trends of Ordering Hypercoagulability Work-Up at an Academic Medical Center.

Authors:  Marjan Alidoost; Gabriella A Conte; Varsha Gupta; Swapnil Patel; Ishan Patel; Mohammed Shariff; Shreya Gor; Michael J Levitt; Arif Asif; Mohammad A Hossain
Journal:  J Blood Med       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.